Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the steadily upward trajectory of the company since ...

Gilead Sciences Inc. CEO Daniel O'Day's compensation rose 4.8% last year to $23.7 million — roughly $97 for every buck made ...

News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top ...

Gilead Sciences stock has room to climb, and investors shouldn’t overlook the company’s impressive record in navigating HIV policy, Citi Research says. Analysts led by Geoff Meacham reiterated a Buy ...

Shares of Gilead Sciences, Inc. dropped nearly 2.5% on Wednesday and extended losses after hours following a report that the ...

As The Handmaid's Tale gets ready to stream its final season, Samira Wiley reveals to TooFab what it felt like for Moira to ...

The Health and Human Services Department is considering cuts to HIV prevention funding, according to The Wall Street Journal.

Bearish flow noted in Gilead (GILD) with 1,949 puts trading, or 1.3x expected. Most active are 4/4 weekly 107 puts and Apr-25 109 puts, with ...

While speaking with TooFab at PaleyFest LA, Samira Wiley opened up bout her journey starring as Moira Strand in The ...

While Season 1 of The Handmaid's Tale was a pretty accurate adaptation of Margaret Atwood's novel of the same name, the ...

Moss brought her baby to the Vancouver set for the sixth and final season of the hit Hulu series, which sees her heroine June ...

Investors with a lot of money to spend have taken a bearish stance on Gilead Sciences GILD. And retail traders should know.